Table 1 Extracted Information of the Included Studies
Author | Year | Country | Type of study | AS diagnostic criteria | sleep disturbance measurement tool | Age | Sample size | Prevalence (%) |
|---|---|---|---|---|---|---|---|---|
Abdulaziez and Asaad(19) | 2012 | Egypt | Cross-sectional study | modified New York classification criteria for AS | PSQI | 37.8 ± 5.6 | 20 | 90 |
Aissaoui et al(34) | 2012 | Morocco | Cross-sectional study | modified New York classification criteria for AS | fourth item of Hamilton anxiety scale | 38.52 ± 12.62 | 110 | 64.5 |
Batmaz et al(28) | 2013 | Turkey | Cross-sectional study | modified New York classification criteria for AS | PSQI | 35.3 ± 6.7 (16–60) | 80 | 50 |
Chen et al(6) | 2021 | Taiwan | Cross-sectional study | modified New York classification criteria for AS | 19th item of PSQI | 45.981 ± 12.157 | 104 | 36.5 |
Demirci et al(14) | 2016 | Turkey | Cross-sectional study | modified New York classification criteria for AS | PSQI | 41(median) | 108 | 64.8 |
Günaydin et al(27) | 2009 | Turkey | Cross-sectional study | modified New York classification criteria for AS | PSQI | 39.6 ± 10.3 | 62 | 54.8 |
Hakkou et al(22) | 2013 | Morocco | Cross-sectional study | modified New York classification criteria for AS | fourth item of Hamilton anxiety scale | 38.5 ± 12.6 | 110 | 64.5 |
Hultgren et al(35) | 2000 | Sweden | Cross-sectional study | modified New York classification criteria for AS | USI | Â | 70 | 62 |
Jiang et al1(16) | 2018 | China | Cross-sectional study | modified New York classification criteria for AS | PSQI | 28.99 ± 8.87 | 2772 | 31 |
Jiang et al2(36) | 2015 | China | Cross-sectional study | modified New York classification criteria for AS | PSQI | 27.33 ± 8.67 | 683 | 37.3 |
Karatas et al(37) | 2018 | Turkey | Prospective study | modified New York classification criteria for AS | PSQI | 37.39 ± 8.01 (18–75) | 34 | 57.9 |
Li et al(38) | 2012 | China | Case-control study | modified New York classification criteria for AS | PSQI | 27.65 ± 8.34 | 314 | 35.4 |
Nie et al(20) | 2018 | China | Cross-sectional study | modified New York classification criteria for AS | PSQI | 31.71 ± 9.80 (14–61) | 281 | 67.6 |
Song et al1(39) | 2021 | Korea | Cross-sectional study | modified New York classification criteria for AS | PSQI | 35.81 ± 11.78 | 107 | 65.4 |
Song et al2(40) | 2017 | China | Cross-sectional study | modified New York classification criteria for AS | PSQI | 31.66 ± 9.69 | 295 | 49.3 |
Tymms et al(10) | 2022 | Australia | Retrospective cross-sectional study | ICD code M45, M45.0 or M08.1 | ISI | 48.3 ± 13.6 (18–95) | 495 | 19.2 |
Ward(41) | 1999 | United States of America | Cross-sectional study | modified New York classification criteria for AS | One of items of a 23-item questionnaire which assesses 23 aspects of health-related quality of life and was validated in this study and used in some previous studies | 51.1 ± 14.0 | 175 | 54.1 |
Yüksel et al(42) | 2019 | Turkey | Cross-sectional study | modified New York classification criteria for AS | PSQI | 39.6 ± 11.3 (21–56) | 20 | 80 |